LifeMD's Q2 2024 earnings were mixed, with management failing to monetize the non-core WorkSimpli asset, leading me to assign it no value. Despite management's over-promising, LifeMD's telehealth and ...
Zacks.com on MSN
LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?
LifeMD, Inc. LFMD shares ended the last trading session 23.7% higher at $5.06. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...
Revenue grew 23% year over year (GAAP) in Q2 2025, but missed analyst estimates by $4.1 million (GAAP). The telehealth segment achieved 30.0% revenue growth, with Adjusted EBITDA rising 560%.
As of November 17, 2025, the average one-year price target for LifeMD is $13.13/share. The forecasts range from a low of $8.08 to a high of $18.90. The average price target represents an increase of ...
LifeMD’s fair value target currently sits at US$9.88, with the latest update keeping that figure unchanged from the prior US$9.88 estimate. Analysts link this steady target to a balance between ...
NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) and reminds ...
LifeMD shares nearly halved in price following a missed earnings report, with subscriber retention being a key issue. LifeMD stock trades at a significant discount to HIMS despite similar subscription ...
NEW YORK, Oct. 15, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeMD, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD) ...
Virtual healthcare platforms are redefining patient access to care, with Hims & Hers Health, Inc. HIMS and LifeMD, Inc. LFMD leading this digital shift. Hims & Hers delivers affordable, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results